OMCL Omnicell Inc

  1. Stocks
  2. Healthcare
  3. NASDAQ: OMCL

Price (delayed)

$32.99

Market cap

$1.5B

P/E Ratio

38.81

Dividend/share

N/A

EPS

$0.85

Enterprise value

$1.4B

Sign up for free to view scoring metrics ?
Relative Growth: Rel. Growth:
Relative Strength: Rel. Strength:
Relative Valuation: Rel. Valuation:
Relative Profitability: Rel. Profitability: 57

Since 1992, Omnicell has been committed to transforming pharmacy and nursing care through outcomes-centric solutions designed to deliver clinical and business outcomes across all settings of care. Through a comprehensive ...

Highlights
OMCL's EPS has soared by 93% from the previous quarter and by 70% YoY
OMCL's net income has surged by 91% since the previous quarter and by 69% year-on-year
Sector: Healthcare
Industry: Health Information Services
Website: http://www.omnicell.com
Peers: STE MCK CAH

Key stats

What are the main financial stats of OMCL

OMCL stock price

How has the Omnicell stock price performed over time
Intraday
-0.54%
1 week
1.73%
1 month
-7.28%
1 year
6.42%
YTD
-27.17%
QTD
-20.54%

Financial performance

How have Omnicell's revenue and profit performed over time
Revenue
$1.25B
Gross profit
$558.13M
Operating income
$57.96M
Net income
$39.08M
Gross margin
44.8%
Net margin
3.1%
OMCL's net income has surged by 91% since the previous quarter and by 69% year-on-year
OMCL's net margin has soared by 82% QoQ and by 55% YoY
The operating income has soared by 72% since the previous quarter
The operating margin has soared by 70% QoQ

Price vs fundamentals

How does OMCL's price correlate with its fundamentals

Growth

What is Omnicell's growth rate over time

Valuation

What is Omnicell stock price valuation
OMCL P/E details
P/E
38.81
P/B
1.16
P/S
1.21
EV/EBIT
24.17
EV/EBITDA
9.84
EV/Sales
1.12
OMCL's EPS has soared by 93% from the previous quarter and by 70% YoY
The P/E is 88% less than the last 4 quarters average of 332.0
The stock's price to book (P/B) is 53% less than its 5-year quarterly average of 2.5 and 16% less than its last 4 quarters average of 1.4
The company's equity rose by 2.8% QoQ and by 2.2% YoY
The stock's P/S is 50% less than its 5-year quarterly average of 2.4 and 14% less than its last 4 quarters average of 1.4
The revenue has grown by 8% year-on-year

Efficiency

How efficient is Omnicell business performance
OMCL's return on assets has surged by 100% since the previous quarter and by 82% year-on-year
The ROE has soared by 94% from the previous quarter and by 72% YoY
OMCL's ROIC has soared by 77% since the previous quarter
OMCL's ROS has soared by 70% from the previous quarter

Dividends

What is OMCL's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for OMCL.

Financial health

How did Omnicell financials performed over time
The company's total assets is 183% higher than its total liabilities
The total liabilities has decreased by 20% YoY and by 5% QoQ
Omnicell's current ratio has increased by 15% YoY and by 9% from the previous quarter
OMCL's debt is 85% lower than its equity
OMCL's debt is down by 49% YoY
OMCL's debt to equity is down by 48% year-on-year

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.